Genetic and chemical knockdown: a complementary strategy for evaluating an anti-infective target

Vasanthi Ramachandran,1,* Ragini Singh,2,* Xiaoyu Yang,1 Ragadeepthi Tunduguru,1 Subrat Mohapatra,2 Swati Khandelwal,2 Sanjana Patel,2 Santanu Datta21AstraZeneca India R&D, Bangalore, India; 2Cellworks India, Bangalore, India *These authors contributed equally to this workAbstract: The e...

Full description

Bibliographic Details
Main Authors: Ramachandran V, Singh R, Yang X, Tunduguru R, Mohapatra S, Khandelwal S, Patel S, Datta S
Format: Article
Language:English
Published: Dove Medical Press 2013-02-01
Series:Advances and Applications in Bioinformatics and Chemistry
Online Access:http://www.dovepress.com/genetic-and-chemical-knockdown-a-complementary-strategy-for-evaluating-a12157
_version_ 1818528636235415552
author Ramachandran V
Singh R
Yang X
Tunduguru R
Mohapatra S
Khandelwal S
Patel S
Datta S
author_facet Ramachandran V
Singh R
Yang X
Tunduguru R
Mohapatra S
Khandelwal S
Patel S
Datta S
author_sort Ramachandran V
collection DOAJ
description Vasanthi Ramachandran,1,* Ragini Singh,2,* Xiaoyu Yang,1 Ragadeepthi Tunduguru,1 Subrat Mohapatra,2 Swati Khandelwal,2 Sanjana Patel,2 Santanu Datta21AstraZeneca India R&D, Bangalore, India; 2Cellworks India, Bangalore, India *These authors contributed equally to this workAbstract: The equity of a drug target is principally evaluated by its genetic vulnerability with tools ranging from antisense- and microRNA-driven knockdowns to induced expression of the target protein. In order to upgrade the process of antibacterial target identification and discern its most effective type of inhibition, an in silico toolbox that evaluates its genetic and chemical vulnerability leading either to stasis or cidal outcome was constructed and validated. By precise simulation and careful experimentation using enolpyruvyl shikimate-3-phosphate synthase and its specific inhibitor glyphosate, it was shown that genetic knockdown is distinct from chemical knockdown. It was also observed that depending on the particular mechanism of inhibition, viz competitive, uncompetitive, and noncompetitive, the antimicrobial potency of an inhibitor could be orders of magnitude different. Susceptibility of Escherichia coli to glyphosate and the lack of it in Mycobacterium tuberculosis could be predicted by the in silico platform. Finally, as predicted and simulated in the in silico platform, the translation of growth inhibition to a cidal effect was able to be demonstrated experimentally by altering the carbon source from sorbitol to glucose.Keywords: knockdown, inhibition, in silico, vulnerability
first_indexed 2024-12-11T06:52:34Z
format Article
id doaj.art-667e0ec04e4d42418053147754940fa4
institution Directory Open Access Journal
issn 1178-6949
language English
last_indexed 2024-12-11T06:52:34Z
publishDate 2013-02-01
publisher Dove Medical Press
record_format Article
series Advances and Applications in Bioinformatics and Chemistry
spelling doaj.art-667e0ec04e4d42418053147754940fa42022-12-22T01:16:51ZengDove Medical PressAdvances and Applications in Bioinformatics and Chemistry1178-69492013-02-012013default113Genetic and chemical knockdown: a complementary strategy for evaluating an anti-infective targetRamachandran VSingh RYang XTunduguru RMohapatra SKhandelwal SPatel SDatta SVasanthi Ramachandran,1,* Ragini Singh,2,* Xiaoyu Yang,1 Ragadeepthi Tunduguru,1 Subrat Mohapatra,2 Swati Khandelwal,2 Sanjana Patel,2 Santanu Datta21AstraZeneca India R&D, Bangalore, India; 2Cellworks India, Bangalore, India *These authors contributed equally to this workAbstract: The equity of a drug target is principally evaluated by its genetic vulnerability with tools ranging from antisense- and microRNA-driven knockdowns to induced expression of the target protein. In order to upgrade the process of antibacterial target identification and discern its most effective type of inhibition, an in silico toolbox that evaluates its genetic and chemical vulnerability leading either to stasis or cidal outcome was constructed and validated. By precise simulation and careful experimentation using enolpyruvyl shikimate-3-phosphate synthase and its specific inhibitor glyphosate, it was shown that genetic knockdown is distinct from chemical knockdown. It was also observed that depending on the particular mechanism of inhibition, viz competitive, uncompetitive, and noncompetitive, the antimicrobial potency of an inhibitor could be orders of magnitude different. Susceptibility of Escherichia coli to glyphosate and the lack of it in Mycobacterium tuberculosis could be predicted by the in silico platform. Finally, as predicted and simulated in the in silico platform, the translation of growth inhibition to a cidal effect was able to be demonstrated experimentally by altering the carbon source from sorbitol to glucose.Keywords: knockdown, inhibition, in silico, vulnerabilityhttp://www.dovepress.com/genetic-and-chemical-knockdown-a-complementary-strategy-for-evaluating-a12157
spellingShingle Ramachandran V
Singh R
Yang X
Tunduguru R
Mohapatra S
Khandelwal S
Patel S
Datta S
Genetic and chemical knockdown: a complementary strategy for evaluating an anti-infective target
Advances and Applications in Bioinformatics and Chemistry
title Genetic and chemical knockdown: a complementary strategy for evaluating an anti-infective target
title_full Genetic and chemical knockdown: a complementary strategy for evaluating an anti-infective target
title_fullStr Genetic and chemical knockdown: a complementary strategy for evaluating an anti-infective target
title_full_unstemmed Genetic and chemical knockdown: a complementary strategy for evaluating an anti-infective target
title_short Genetic and chemical knockdown: a complementary strategy for evaluating an anti-infective target
title_sort genetic and chemical knockdown a complementary strategy for evaluating an anti infective target
url http://www.dovepress.com/genetic-and-chemical-knockdown-a-complementary-strategy-for-evaluating-a12157
work_keys_str_mv AT ramachandranv geneticandchemicalknockdownacomplementarystrategyforevaluatinganantiinfectivetarget
AT singhr geneticandchemicalknockdownacomplementarystrategyforevaluatinganantiinfectivetarget
AT yangx geneticandchemicalknockdownacomplementarystrategyforevaluatinganantiinfectivetarget
AT tundugurur geneticandchemicalknockdownacomplementarystrategyforevaluatinganantiinfectivetarget
AT mohapatras geneticandchemicalknockdownacomplementarystrategyforevaluatinganantiinfectivetarget
AT khandelwals geneticandchemicalknockdownacomplementarystrategyforevaluatinganantiinfectivetarget
AT patels geneticandchemicalknockdownacomplementarystrategyforevaluatinganantiinfectivetarget
AT dattas geneticandchemicalknockdownacomplementarystrategyforevaluatinganantiinfectivetarget